iSAM Funds (UK)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Buy
+16,000
New +$2.11M 1.43% 7
2025
Q3
Sell
-3,641
Closed -$404K 701
2025
Q2
$404K Buy
+3,641
New +$387K 0.09% 308
2024
Q3
Sell
-6,106
Closed -$419K 339
2024
Q2
$419K Buy
+6,106
New +$407K 0.31% 118
2023
Q3
Sell
-8,149
Closed -$628K 275
2023
Q2
$628K Buy
+8,149
New +$650K 0.56% 64

Other funds holding GILD

iSAM Funds (UK)'s GILD Position: Q2 2026 in Review

iSAM Funds (UK) opened a new position in Gilead Sciences (GILD) in Q2 2026: 16,000 shares worth $2.02M. The stake represents 1.43% of the portfolio and ranks #7 among its holdings. This is a return to the name: iSAM Funds (UK) previously reported a position in GILD as recently as Q2 2025.

iSAM Funds (UK) first reported a position in GILD in Q2 2023 and has held it in 4 quarters since. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • iSAM Funds (UK) held 16,000 shares of Gilead Sciences worth $2.02M as of Q2 2026.
  • Gilead Sciences was a new iSAM Funds (UK) position in Q2 2026.
  • Gilead Sciences made up 1.43% of iSAM Funds (UK)'s portfolio in Q2 2026, its #7 holding.
  • iSAM Funds (UK) first reported a position in Gilead Sciences in Q2 2023 and has held it in 4 quarters since.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on iSAM Funds (UK)'s 13F filing for Q2 2026, filed 12 Aug 2026.